Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
44,531,209
-
Share change
-
-190,543
-
Total reported value
-
$27,243,487
-
Put/Call ratio
-
138%
-
Price per share
-
$0.62
-
Number of holders
-
69
-
Value change
-
-$708,085
-
Number of buys
-
32
-
Number of sells
-
35
Institutional Holders of CORBUS PHARMACEUTICALS HLDGS - COM (CRBP) as of Q4 2021
As of 31 Dec 2021,
CORBUS PHARMACEUTICALS HLDGS - COM (CRBP) was held by
69 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
44,531,209 shares.
The largest 10 holders included
ETF MANAGERS GROUP, LLC, VANGUARD GROUP INC, Knoll Capital Management, LLC, Mirae Asset Global Investments Co., Ltd., BlackRock Inc., MORGAN STANLEY, GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, CITADEL ADVISORS LLC, and Ikarian Capital, LLC.
This page lists
69
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.